Amplia Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Amplia Therapeutics has a total shareholder equity of A$11.4M and total debt of A$1.5M, which brings its debt-to-equity ratio to 13.1%. Its total assets and total liabilities are A$14.8M and A$3.4M respectively.
Key information
13.1%
Debt to equity ratio
AU$1.49m
Debt
Interest coverage ratio | n/a |
Cash | AU$3.39m |
Equity | AU$11.42m |
Total liabilities | AU$3.43m |
Total assets | AU$14.85m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: INNM.F's short term assets (A$6.8M) exceed its short term liabilities (A$3.4M).
Long Term Liabilities: INNM.F's short term assets (A$6.8M) exceed its long term liabilities (A$23.4K).
Debt to Equity History and Analysis
Debt Level: INNM.F has more cash than its total debt.
Reducing Debt: INNM.F's debt to equity ratio has increased from 0% to 13.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: INNM.F has sufficient cash runway for 8 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: INNM.F is forecast to have sufficient cash runway for 8 months based on free cash flow estimates, but has since raised additional capital.